Search research articles
Contact Us
Filters
Showing results (91-100 of 218) with videos related to
Page
of 22
Sort By:
Acta Neuropathologica
|
March 9, 2019
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF<sup>V600E</sup> mutation
David W Ellison, Cynthia Hawkins, David T W Jones, et al.
Journal of Neuropathology and Experimental Neurology
|
February 7, 2002
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"
Hikaru Sasaki, Magdalena C Zlatescu, Rebecca A Betensky, et al.
Journal of Cutaneous Pathology
|
January 26, 2023
Atretic cephalocele and encephalocele: A single-institution clinicopathological study
Melanie Lang-Orsini, Samantha N Champion, Ann-Christine Duhaime, et al.
Acta Neuropathologica
|
July 10, 2007
The 2007 WHO classification of tumours of the central nervous system
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, et al.
Neuro-Oncology
|
October 11, 2017
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C DeWitt, Justin T Jordan, Matthew P Frosch, et al.
Pain
|
July 12, 2003
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres
Daniel S Kohane, Sarah E Smith, David N Louis, et al.
Journal of Neuropathology and Experimental Neurology
|
December 6, 2006
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2
Audrey Rousseau, Catherine L Nutt, Rebecca A Betensky, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2014
Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia
Robert T Jones, Malak S Abedalthagafi, Mohan Brahmandam, et al.
Journal of the National Cancer Institute
|
December 17, 2011
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells
Ryuichi Kanai, Samuel D Rabkin, Stephen Yip, et al.
Journal of Neuro-Oncology
|
July 16, 2016
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)
Quinn T Ostrom, Haley Gittleman, Carol Kruchko, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 218) with videos related to
Sort By:
Page
of 22
Acta Neuropathologica
|
March 9, 2019
cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF<sup>V600E</sup> mutation
David W Ellison, Cynthia Hawkins, David T W Jones, et al.
Journal of Neuropathology and Experimental Neurology
|
February 7, 2002
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"
Hikaru Sasaki, Magdalena C Zlatescu, Rebecca A Betensky, et al.
Journal of Cutaneous Pathology
|
January 26, 2023
Atretic cephalocele and encephalocele: A single-institution clinicopathological study
Melanie Lang-Orsini, Samantha N Champion, Ann-Christine Duhaime, et al.
Acta Neuropathologica
|
July 10, 2007
The 2007 WHO classification of tumours of the central nervous system
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, et al.
Neuro-Oncology
|
October 11, 2017
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C DeWitt, Justin T Jordan, Matthew P Frosch, et al.
Pain
|
July 12, 2003
Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres
Daniel S Kohane, Sarah E Smith, David N Louis, et al.
Journal of Neuropathology and Experimental Neurology
|
December 6, 2006
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2
Audrey Rousseau, Catherine L Nutt, Rebecca A Betensky, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 22, 2014
Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia
Robert T Jones, Malak S Abedalthagafi, Mohan Brahmandam, et al.
Journal of the National Cancer Institute
|
December 17, 2011
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells
Ryuichi Kanai, Samuel D Rabkin, Stephen Yip, et al.
Journal of Neuro-Oncology
|
July 16, 2016
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)
Quinn T Ostrom, Haley Gittleman, Carol Kruchko, et al.
Page
of 22